Baxter
BAX
#1106
Rank
NZ$29.90 B
Marketcap
$57.30
Share price
-1.96%
Change (1 day)
-17.71%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

P/S ratio for Baxter (BAX)

P/S ratio as of March 2025 (TTM): 1.34

According to Baxter's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.45. At the end of 2024 the company had a P/S ratio of 1.16.

P/S ratio history for Baxter from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.16-18.97%
20231.43-17.58%
20221.74-48.35%
20213.36-4.25%
20203.51-5.74%
20193.7322.69%
20183.04-8.95%
20173.3340.52%
20162.3713.22%
20152.10-19.94%
20142.625.33%
20132.49-3.13%
20122.5727.77%
20112.01-12.26%
20102.29-18.46%
20092.814.3%
20082.69-17.69%
20073.2712.46%
20062.9121.72%
20052.396.43%
20042.246.73%
20032.100.67%
20022.09-50.16%
20014.19

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
0.1448-89.17%๐Ÿ‡บ๐Ÿ‡ธ USA
6.32 372.68%๐Ÿ‡บ๐Ÿ‡ธ USA
9.10 580.87%๐Ÿ‡บ๐Ÿ‡ธ USA
3.19 138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
7.89 489.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.57 242.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
0.0669-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
3.48 160.39%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
1.54 15.37%๐Ÿ‡บ๐Ÿ‡ธ USA